Why?
Unlocking the mitochondrial axis: [18F]F-AraG as a cross-disease imaging biomarker in immuno-oncology, cardiology and neuroinflammation.
June 12th, 2025
Dr. Jelena Levi, CellSight’s CSO, delivered the 2025 Aruna Bodapati Gambhir Lecture as part of Stanford’s Molecular Imaging Seminar Series. She highlighted the unique capabilities of [¹⁸F]F‑AraG to image both immune activation and mitochondrial function, underscoring its broad potential as a cross-disease biomarker platform with broad translational impact.
Role of [18F]F-AraG in assessing systemic immunity
February 8th, 2025
An overview of preclinical and clinical investigations of [18F]F-AraG in evaluating systemic immunity was presented at the Indo-American Society of Nuclear Medicine (IASNM) Radiant Flashpoints Educational Web-Series, organized in honor of Dr. Sanjiv Sam Gambhir
[18F]F-AraG in monitoring response and predicting outcomes in patients with cancer treated with PD-(L)1 therapy
December 6th, 2024
[18F]F-AraG’s ability to evaluate immune contexture within the tumor microenvironment as well as systemic immunity in patients with cancer treated with immunotherapy was presented at the 4th International congress on inflammation and infection imaging in Rome, Italy.
[18F]F-AraG uptake in the vertebral bone marrow predicts survival in immunotherapy treated non-small cell lung cancer patients
September 9th, 2024
The study by Dr. Levi et al. was recognized as one of the top abstracts at the 2024 WMIC in Montreal, Canada.
[18F]F-AraG reveals long-term immune system activation following COVID-19 infection
July 3rd, 2024
The USCF study by Peluso M.J. et al., which reported T cell activation and viral persistence in several tissues in post-acute COVID-19 participants, has made the cover of Science Translational Medicine, Volume 16, Issue 754.
[18F]F-AraG imaging reveals association between neuroinflammation and brown- and bone marrow adipose tissue
June 10th, 2024
Collaborative project between CellSight, UCSF, UC Davis, Dana Farber and Stanford University that used 18F-AraG to demonstrate a connection between neuroinflammation and adipose tissue is presented at the SNMMI 2024 in Toronto.